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Macrophages are distributed in tissues throughout the body and contribute to both homeostasis and
disease. Recently, it has become evident that most adult tissue macrophages originate during embryonic
development and not from circulating monocytes. Each tissue has its own composition of embryonically
derived and adult-derived macrophages, but it is unclear whether macrophages of distinct origins are func-
tionally interchangeable or have unique roles at steady state. This new understanding also prompts recon-
sideration of the function of circulating monocytes. Classical Ly6chi monocytes patrol the extravascular
space in resting organs, and Ly6clo nonclassical monocytes patrol the vasculature. Inflammation triggers
monocytes to differentiate into macrophages, but whether resident and newly recruited macrophages
possess similar functions during inflammation is unclear. Here, we define the tools used for identifying the
complex origin of tissue macrophages and discuss the relative contributions of tissue niche versus ontolog-
ical origin to the regulation of macrophage functions during steady state and inflammation.Introduction
The Phagocyte: Ilya Metchnikoff and the Historical
Perspective
Macrophages were first discovered late in the 19th century by
Ilya Metchnikoff and are evolutionary conserved phagocytes
that evolved more than 500 million years ago (Cooper and Alder,
2006; Tauber, 2003). Metchnikoff combined both evolutionary
and ontological perspectives, which is particularly relevant in
light of recent findings that have revolutionized the macrophage
field. In the 1960s, van Furth proposed that all tissue macro-
phages originate from circulating adult blood monocytes, which
has been the prevailing view for the last 40 years despite evi-
dence that tissue macrophages are independent of circulating
monocytes (van Furth and Cohn, 1968; Volkman et al., 1983;
Sawyer et al., 1982). However, in the last few years, a series of
more definitive publications have drastically revised our under-
standing of macrophage origin by demonstrating that many
resident tissue macrophages are in fact established during em-
bryonic development and persist into adulthood independently
of blood monocyte input in the steady state (Ginhoux et al.,
2010; Schulz et al., 2012; Yona et al., 2013; Hashimoto et al.,
2013; Epelman et al., 2014; Guilliams et al., 2013; Jakubzick
et al., 2013). Metchnikoff defined the embryonic establishment
of macrophages in the starfish, which has no formal vascular
system. Accordingly, he argued for inflammation independent
of blood vessels, countering Julius Cohnheim’s duly influential
claims that ‘‘there is no inflammation without blood vessels.’’
Thus, in the 21st century, we have come full circle to these de-
bates with the reality that inflammation, even in organisms
anatomically more complex than starfish, centrally involvesmac-
rophages but can occur through mechanisms that are both
dependent and independent of monocyte recruitment from the
vasculature. Self-sustaining resident macrophages already pre-
sent in the tissue make this possible.
As our tools develop, we continue to refine our understanding
of tissue macrophages and can now further delineate multipledistinct embryonically derived macrophage lineages. Several
detailed review articles describing different aspects of macro-
phage ontogeny and function have been published (Sieweke
and Allen, 2013; Davies et al., 2013a; Wynn et al., 2013).
Although a novel concept in and of itself, the dichotomy between
embryonically derived and adult-derived macrophage popu-
lations does not fully encapsulate the entire complexity and
diversity found among tissue macrophages. Intriguingly, tissue
macrophages of differing ontological origins coexist, and when
assessed as a group, they perform specialized, organ-specific
functions. The goal of this review is to highlight emerging ques-
tions in the field, such as to what extent macrophage ontogeny
versus the tissue niche dictates a macrophage’s function. Are
we missing critical insight by not parsing macrophage function
on the basis of origin? To what extent is there redundancy
between adult-monocyte-derived macrophages and different
resident macrophage subsets? We will utilize this framework to
discuss how subsets of tissue macrophages and circulating
monocytes originate, how expansion of tissue macrophages is
regulated when homeostasis is disrupted, and what functions
can be ascribed to individual subsets and lineages.
Understanding the Tools Used for Defining Macrophage
Ontogeny
During early gestation (embryonic day 6.5 [E6.5]–E8.5), macro-
phages are first observed and expand in the extraembryonic
yolk sac during what is termed primitive hematopoiesis (Sa-
mokhvalov, 2014) (see Figure 1). At this stage in development,
macrophages are the only ‘‘white blood cell’’ produced, because
restricted progenitors in the yolk sac give rise only to macro-
phages and red blood cells. This limited hematopoietic cell diver-
sity is reminiscent of the Drosophila immune system (Makhijani
and Bru¨ckner, 2012) and indicative of the conserved origin
of the yolk-sac-derived macrophage lineage. Subsequently
(E8.5–E10.5), definitive hematopoietic stem cells (HSCs) emerge
from the aorta-gonad-mesonephros and give rise to all immuneImmunity 41, July 17, 2014 ª2014 Elsevier Inc. 21
Figure 1. Macrophage Lineages, Ontogeny, and Contribution to Populations of Resident Tissue Macrophages
(A) Schematic depicting the origins of embryonic and adult macrophage lineages. Genetic lineage tracing using Flt3Cre and direct labeling techniques, including
Csf1rCreER and Runx1CreER, allow identification of adult-monocyte-derived and yolk-sac-derived macrophages. There are no available tools for lineage tracing of
fetal-liver-monocyte-derived macrophages only.
(B) Contribution of macrophage lineages to populations of adult resident macrophages. HSC-derived populations include embryonic populations and no
definitive evidence of yolk sac origin (embryonic), whereas HSCs (adult) have passed through a FLT3+ stage (Flt3-Cre+) and are continually replaced by circulating
adult monocytes.
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which then serves as the major hematopoietic organ during the
remainder of embryonic development. Only in the perinatal
period do traditional bone marrow HSCs become the primary
site of hematopoiesis and produce the full complement of im-
mune lineages (Orkin and Zon, 2008).
During embryonic development, transcription factor usage
and surface-marker expression differ between yolk-sac-derived
and definitive-HSC-derived macrophages. Definitive HSCs are
completely dependent on the transcription factor MYB, whereas
yolk-sac-derived progenitors develop independently of MYB
(Schulz et al., 2012). Furthermore, during embryogenesis, yolk-
sac-derived macrophages have a characteristic CX3CR1hi
F4/80hiCD11blo expression pattern (Schulz et al., 2012; Yona
et al., 2013; Hashimoto et al., 2013; Epelman et al., 2014). Unfor-
tunately, many adult resident tissue macrophages that originate
during embryonic development alter the expression of cell-sur-22 Immunity 41, July 17, 2014 ª2014 Elsevier Inc.face markers as the animal matures, hindering the ability to pre-
cisely track macrophage populations. Clear examples include
embryonically established tissue macrophages that express
CX3CR1 during development (lung and peritoneal macrophages
and liver Kupffer cells) but lose expression after birth (Yona et al.,
2013).
Genetic fate-mapping techniques give us the ability to pre-
cisely identify and track different embryonic macrophage popu-
lations into adulthood, and when combined with parabiotic and
adoptive-transplant studies, they give us the ability to discern
the relationship between macrophages and circulating blood
monocytes. Fate-mapping studies utilize the principle of genetic
recombination to permanently label cells (and all subsequent
progeny) on the basis of the recombination-induced expression
of a reporter gene that is under the control of a constitutive
promoter (typically Rosa26). Genetic techniques have evolved
to include inducible systems, where temporally controlling
Table 1. Tools Used for Defining Macrophage Lineages
Strategy Result Strength Limitation References
Runx1CreER identifies yolk-sac-
derived macrophages
is expressed very early
during development
has a very limited
window; results in
incomplete labeling
during development
Hoeffel et al. (2012);
Ginhoux et al. (2010)
Csf1rCreER identifies yolk-sac-
derived macrophages
is expressed very early
during development;
has a longer window
than Runx1CreER
results in incomplete
labeling during
development
Epelman et al. (2014);
Schulz et al. (2012)
Flt3Cre defines cells that pass
through definitive
hematopoiesis (HSCs)
has strong reporter
induction in circulating
monocytes in adult
animals; differentiates
well between embryonic
and adult macrophages;
is excellent at following
population dynamics
during stress
does not differentiate
well between embryonic
lineages (yolk sac versus
fetal monocytes); might
not label some HSC-
derived macrophages
during times of rapid
expansion (i.e., in early
development or after
adoptive transplant)
Epelman et al. (2014);
Schulz et al. (2012);
Hashimoto et al. (2013);
Boyer et al. (2011)
Cx3cr1GFP/+ identifies cells currently
expressing CX3CR1
CX3CR1hi macrophages
correspond well to
yolk-sac-derived
F4/80hiCD11blo
macrophages during
development only
is not reliable for
differentiating lineages
in the adult
Yona et al. (2013);
Jung et al. (2000)
Cx3cr1Cre labels all cells that pass
through a CX3CR1+
stage
identifies traditionally
CX3CR1 populations as
having passed through
the CX3CR1+ stage
is less useful for
differentiating between
recruited and resident
macrophages in the adult
Yona et al. (2013)
Cx3cr1CreER has the potential to label
embryonic macrophages
at different stages of
development
identifies very strong
reporter expression in
tissue macrophages
expressing high levels of
CX3CR1; only transiently
labels monocytes, which
allows for differential
targeting
is limited to tissue
macrophages that
express CX3CR1
at the time of induction
Yona et al. (2013);
Goldmann et al. (2013);
Parkhurst et al. (2013)
Rag1Cre identifies lymphomyeloid
progenitors
is the only technique for
specifically labeling
lymphomyeloid
progenitors
it is unclear whether
progeny persist into
adulthood
Bo¨iers et al. (2013)
Parabiosis demonstrates tissue-
specific replacement of
resident macrophages
by chimeric monocytes
does not use irradiation;
turnover is dependent on
the steady state rather
than tissue injury; use
of Ccr2/ recipients
increases chimerism
to >90%
typically demonstrates
only 30% chimerism in
wild-type mice; surgery
might alter steady-state
trafficking
Hashimoto et al. (2013);
Epelman et al. (2014);
Ajami et al. (2011);
Ajami et al. (2007)
Sublethal irradiation
and bone marrow
transplant
induces chimerism in
blood monocytes without
eradicating resident
macrophages
demonstrates blood
monocyte dependence
of tissue macrophages
over long periods of time;
tissue shielding can
minimize local radiation
injury
radiation might alter
steady dynamics (i.e.,
injured tissue recruits
monocytes)
Epelman et al. (2014)
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tions and tracking into adulthood. Below, wewill discuss in detail
experimental evidence that undergirds the recently revised viewof macrophage origins and identify both the strengths and the
limitations of each approach (see a summary of tools used for
defining macrophage origin in Table 1).Immunity 41, July 17, 2014 ª2014 Elsevier Inc. 23
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based system takes advantage of the early expression of
Runx1 in the yolk sac at E7.0, which occurs prior to the devel-
opment of definitive HSCs (Samokhvalov et al., 2007). Labeling
of E7.0 Runx1-expressing yolk-sac-derived macrophages dem-
onstrates that they persist faithfully into adulthood as microglia.
Skin Langerhans cells contain both yolk-sac-derived and fetal-
monocyte-derived populations, but fetal-monocyte-derived
macrophages have become the dominant lineage over time
(Hoeffel et al., 2012; Ginhoux et al., 2010). Whereas early labeling
techniques (prior to E7.5) enable specific tracking of yolk-sac-
derived macrophages (such as microglia), labeling between
E8.0 and E10.5 leads to recombination in both yolk-sac-derived
macrophages and early definitive HSCs, which migrate to the
fetal liver and give rise to blood monocytes and lymphocytes
(Ginhoux et al., 2010; Samokhvalov et al., 2007). As a result,
the ability of Runx1CreER to differentiate between tissue macro-
phages and bloodmonocytes during later developmental stages
becomes obscured.
The inducible Csf1rCreER has also been used for fate-mapping
approaches. Initially, it was observed that E8.5-labeled (yolk-
sac-derived macrophages) seed virtually all developing tissues
in the embryo and show variable persistence into adulthood
(Schulz et al., 2012). Similar to Runx1CreER, Csf1rCreER used at
E8.5 in a separate study achieved 30% labeling of yolk-sac-
derived macrophages in the embryo and persistent labeling of
microglia at the same rate in adults, confirming the near exclu-
sive yolk sac origin of these cells (Epelman et al., 2014). The
only other adult organs that retained significant numbers of
yolk-sac-derived macrophages that originated from E8.5 were
the heart and liver, suggesting that the persistence of early
yolk-sac-derived macrophages might be more restricted than
currently appreciated. However, given that yolk sac progenitors
migrate to the fetal liver at later stages of development, the pos-
sibility exists that these progenitors can continue to give rise to
adult tissue macrophages. Unlike using Runx1CreER, using
Csf1rCreER to label at E8.5 did not result in labeling of adult circu-
lating blood monocytes, suggesting that a longer window for
fate-mapping studies might exist. Two important caveats should
be highlighted. First, unlikeRunx1CreER,Csf1rCreER is a transgene
and might not report native gene expression in all conditions.
Second, the precision of any tamoxifen-inducible system that
requires temporal activation is limited because of the half-life
of tamoxifen. For example, labeling early yolk sac progenitors
at E8.5 could be confounded by the persistence of tamoxifen
in tissue and labeling at later developmental stages, which un-
derscores the importance of monitoring recombination not only
in tissue macrophages but also in later HSC-derived cells.
Adult definitive HSCs transiently pass through a FLT3+ stage
during differentiation into all lineages (myeloid, lymphoid, mega-
karocyte, and erythroid cells), which can be exploited genetically
(Flt3Cre) for labeling adult-definitive-HSC-derived cells (Boyer
et al., 2011). What is clear is that Flt3-Cre+ blood monocytes
do not replace Flt3-Cre tissue macrophage populations, even
over extended periods of time (Epelman et al., 2014; Hashimoto
et al., 2013; Schulz et al., 2012). Interpreting the ontological origin
of Flt3-Cre macrophages must be handled with care because
it might be tempting to assume that the entire population
developed from yolk-sac-derived progenitors, but this remains24 Immunity 41, July 17, 2014 ª2014 Elsevier Inc.unclear. During situations where there is high demand (after
macrophage depletion), the efficiency of Flt3Cre-dependent
recombination within myeloid cells is reduced in comparison to
the steady state. This represents a general limitation of Cre-
dependent lineage-tracing systems. For example, after adoptive
transplant of E14.5 fetal-liver definitive HSCs into sublethally irra-
diated adult animals, it takes8 weeks for Flt3Cre recombination
to reach steady state in circulating blood monocytes. Prior to
8weeks posttransplant, large numbers of Flt3-Crebloodmono-
cytes differentiate into long-lasting resident tissue macrophages
(Epelman et al., 2014). Therefore, during times of high monocyte
demand, HSC-derived monocytes appear to originate in a FLT3-
independent fashion (Flt3-Cre).
Additional complexity surrounds the observation that during
early embryonic development, <5% of phenotypically MYB-
dependent macrophages (HSC derived) display Flt3Cre-depen-
dent recombination (Epelman et al., 2014). On the basis of
available data, these cells might be derived from fetal-liver
monocytes. Therefore, it is possible that Flt3-Cre tissue macro-
phages in the adult consist of a mixed population containing
macrophages derived from both the yolk sac and fetal mono-
cytes (Epelman et al., 2014) (see Figure 1). The ontological and
functional relationship between Flt3-Cre+ versus Flt3-Cre fetal
monocytes and adult-monocyte-derived macrophages is unde-
fined. Conversely, it might be tempting to assume that Flt3-Cre+
tissue macrophages are continually replenished by Flt3-Cre+
circulating bloodmonocytes. Adoptive transplant and parabiotic
studies suggest that in the majority of organs, HSC-derived
macrophages—except for gut CX3CR1hi macrophages, cardiac
CCR2+ macrophages, and dermal macrophage populations—
also exist autonomously from circulating blood monocytes
(Hashimoto et al., 2013; Epelman et al., 2014; Yona et al.,
2013; Jakubzick et al., 2013). Consistent with these observa-
tions, lung macrophages that reside in the alveolus develop
shortly after birth from HSC-derived fetal monocytes but are
not replaced by circulating adult monocytes during parabiosis
studies (Guilliams et al., 2013; Jakubzick et al., 2013).
A limitation of current fate-mapping strategies is that during
embryonic development, incomplete labeling of monocyte and
macrophage populations is invariably obtained. In part, this
represents a technical limitation related to both the duration
and levels of CRE expression—rapidly dividing progenitors
might be too short-lived to permit recombination. However, an
intriguing alternative interpretation is that in addition to incom-
plete labeling, embryonic macrophage lineages other than those
derived from fetal monocytes and yolk sac progenitors might
exist. In support of this possibility, Rag1Cre lineage tracing has
identified a novel lymphomyeloid progenitor population that
precedes the development of definitive HSCs (Bo¨iers et al.,
2013). As the name implies, lymphomyeloid cells give rise to
only lymphocytes and monocytes, but not megakaroycoytes or
erythrocytes. Lymphomyeloid progenitors develop at E8.5–
E9.5 through a RAG1+ progenitor and migrate to the fetal liver.
Detailed analysis of fetal-liver-derived macrophages suggests
that this subset is outcompeted over time by RAG1-independent
macrophages (derived from fetal monocytes and/or the yolk
sac). At E14.5 microglia, skin and liver macrophages were not
labeled, suggesting that RAG-1-derived macrophages were
significantly lost by this time point (Bo¨iers et al., 2013; Schulz
Figure 2. The Life Cycle of Monocyte Subsets and Macrophages in Resting and Inflamed Tissues
In the vasculature, classical Ly6ChiCD43 monocytes give rise to nonclassical Ly6CloCD43+ monocytes through an NR4A1-dependent manner (dashed black
arrow). Nonclassical monocytes go on to patrol the intravascular endothelial cell surface to clear dying endothelial cells. Classical monocytes can exit the
bloodstream and have the capacity to patrol extravascular tissues. These tissue monocytes can transport antigens to lymph nodes with minimal differentiation
changes from their state in blood, although a proportion can convert to Ly6Clo monocytes. However, in the context of inflammation, classical monocytes readily
differentiate to macrophages. These monocyte-derived macrophages are distinct from resident macrophages, which in many organs are embryonically derived
and capable of sustaining themselves by local proliferation. Both recruited and resident macrophages share the capacity for proliferation in tissue during
inflammation.
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dependentmacrophages persist into adulthood as long-lived tis-
sue macrophages.
Monocyte-Specific Origins and Functions
In the adult, monocytes originate from definitive HSCs through a
characterized differentiation program involving progressively
further committed progenitors. The identification of the mono-
cyte-macrophage dendritic cell (DC) progenitor (MDP) provided
a developmental link between both DCs and monocytes within a
common differentiation pathway (Fogg et al., 2006). Recently, a
Ly6c+ monocyte-specific progenitor downstream of MDPs has
been identified in the bone marrow and spleen. Although this
progenitor displays proliferative capacity, unlike mature mono-
cytes, it lacks phagocytic activity (Hettinger et al., 2013). Our cur-
rent understanding of monocytes suggests that there are two
principle subsets: (1) classical Ly6chi monocytes, which appear
to be directly descendent from Ly6c+ monocyte progenitors,
and (2) Ly6clo nonclassical monocytes, which differentiate from
Ly6chi monocytes through an Nr4a1-dependent transcriptional
program (Hanna et al., 2011; Hettinger et al., 2013; Yona et al.,
2013) (Figure 2). These monocyte subsets are highly conserved
and transcriptionally closely match human monocyte subsets
(Ingersoll et al., 2010). In both humans and mice, a third mono-
cyte subset has also been suggested; it resembles an intermedi-
ate population between classical and nonclassical monocytes
on the basis of cell-surface markers and transcriptional analysis.
However, the function of this subset has not been well investi-
gated (Schmidl et al., 2014).
The biology of the nonclassical subset of monocytes is
unusual in that these cells appear primarily to function within
the vasculature itself. They ‘‘patrol’’ the vasculature by slowly
crawling over the endothelium, even moving against the flow of
blood, in a manner dependent upon LFA-1 integrin (Auffray
et al., 2007). The purpose of this behavior has recently been
elucidated. Patrolling, nonclassical monocytes have a key role
in clearing damaged endothelial cells, thereby maintaining
integrity of the vasculature (Carlin et al., 2013). Although some in-
vestigators have considered these monocytes to be vascular‘‘macrophages,’’ they closely cluster with other monocytes and
do not express the core, mature macrophage signature of
mRNA transcripts, including Mer tyrosine kinase (Gautier et al.,
2012b; Jakubzick et al., 2013).
Although they are often referred to as ‘‘inflammatory mono-
cytes,’’ recent work indicates that Ly6chi monocytes can enter
resting tissues. In this capacity, they patrol extravascular tissues
to pick up antigens for transport to draining lymph nodes, all the
while remaining relatively undifferentiated rather than commit-
ting to macrophages or DCs (Jakubzick et al., 2013). However,
in the context of inflammation, recruited monocytes differentiate
to macrophages (Jakubzick et al., 2013). Thus, monocytes of
both subsets carry out a patrolling function in resting mice—
the classical monocyte subset patrols extravascular tissues,
and the nonclassical subset patrols the intravascular space
(Figure 2). This patrolling feature distinguishes monocytes from
macrophages, which have a limited ability to emigrate in com-
parison to monocytes. Once in tissue, Ly6Chi monocytes can
take on many characteristics of Ly6Clo monocytes (Arnold
et al., 2007; Hilgendorf et al., 2014) and enter the lymphatics after
such conversion (Qu et al., 2004) (Figure 2).
In summary, a combination of approaches have greatly
informed our understanding of the diversity and complex onto-
logical origins of resident tissue macrophages (see Figure 1).
Each organ has its own particular composition of embryonically
derived and adult-derived macrophage subsets, and each organ
dictates the degree to which circulating monocytes replace
resident macrophages after birth. As we continually refine our
understanding of macrophage lineage, an important new goal
is to determine the functions of these cells, both through direct
targeting of individual macrophage subsets and through reflect-
ing on prior studies and putting into context observations that
were made prior to the revelation that embryonically derived
macrophages exist.
The Developing Embryo and Macrophage Function
Perhaps the simplest way to learn what functions embryonically
derived macrophages might possess in the adult is to firstImmunity 41, July 17, 2014 ª2014 Elsevier Inc. 25
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this way, we can determine whether macrophage functions
executed in the embryo are ‘‘hard wired’’ and specifically re-
tained by these subsets in the adult. Mice deficient in PU.1,
CSF1R, or M-CSF (CSF1) lack many tissue macrophages from
the earliest stages of development beginning at the time of
yolk sac hematopoiesis. These animals display increased peri-
natal mortality, reduced postnatal survival, and stunted growth
(Dai et al., 2002; McKercher et al., 1996; Wiktor-Jedrzejczak
et al., 1990). Careful examination of macrophage-deficient em-
bryos has revealed defects in embryonic vascular development.
Spi1/ and Csf1op/op animals demonstrate reduced CNS
vascular complexity and branching as early as E11.5 (Nucera
et al., 2011; Fantin et al., 2010; Arnold and Betsholtz, 2013).
Elegant experiments utilizing zebrafish and genetic mouse
models have revealed that macrophages orchestrate CNS
vascular development by acting as endothelial cell chaperones
promoting endothelial tip cell fusion in a VEGF-A-independent
manner (Fantin et al., 2010). Intriguingly, macrophages found in
the developing retina are required for blood vessel regression
through a noncanonical WNT- and FLT1-dependent mechanism
(Lobov et al., 2005), indicating that macrophages might interact
with the developing vasculature in distinct ways depending on
the tissue context.
In addition to regulating embryonic vascular growth and
patterning, macrophages participate in other important pro-
cesses during development. In the developing brain, microglia
mediate neuronal patterning through regulation of neuronal
survival and programmed cell death (Wake et al., 2013; Nayak
et al., 2014). With respect to neuronal survival, microglia are
essential for cortical layer V formation, where they release
multiple growth factors, including IGF-1 (Ueno et al., 2013).
Conversely, microglia pattern the developing hippocampus
and cerebellum by triggering the death of excess neurons
through DAP12 signaling and the release of reactive oxygen
species (Marı´n-Teva et al., 2004;Wakselman et al., 2008). Micro-
glia-induced neuronal cell death is accompanied by minimal
inflammation and rapid phagocytosis of apoptotic neurons.
Similarly, microglia play essential roles in synaptic patterning
by using DAP12-, CX3CR1-, and complement-dependentmech-
anisms (Paolicelli et al., 2011; Roumier et al., 2004; Stevens et al.,
2007). Recently, a more general role for embryonic macro-
phages in the clearance of senescent cells during embryonic
development was described (Mun˜oz-Espı´n et al., 2013; Storer
et al., 2013).
A common feature of Csf1op/op, Csf1r/, and Spi1/mice is
defective long-bone formation, tooth eruption, and osteopetro-
sis (Dai et al., 2002; Wiktor-Jedrzejczak et al., 1990; Tondravi
et al., 1997). Each of these phenotypes is a consequence of
failed osteoclast development. Osteoclasts are terminally differ-
entiated macrophage-derived cells with specialized functions in
bone remodeling. With respect to long-bone formation, macro-
phage-deficient embryos display defects in growth-plate
dynamics, fail to undergo timely endochondrial ossification,
and contain increased numbers of hypertrophic chondrocytes
(Ortega et al., 2010). Failed tooth eruption and osteopetrosis
are a direct result of deficiencies in osteoclast-mediated bone
demineralization and remodeling (Kodama et al., 1991). It is not
entirely known from what macrophage lineage(s) osteoclasts26 Immunity 41, July 17, 2014 ª2014 Elsevier Inc.are derived. In the adult mouse, parabiosis studies have revealed
that monocytes can be recruited to the bone and differentiate to
osteoclasts. By using a transgenic mouse expressing a photo-
convertable GFP molecule (Kikume Green-Red), Kotani et al.
(2013) identified a contribution of splenic monocytes to osteo-
clasts. This study did not employ genetic lineage-tracing tech-
niques, and although adult monocytes can contribute to the
osteoclast pool, it remains unclear to what degree and whether
embryonically derived macrophages do as well. Moreover, the
ontogeny of osteoclasts during embryonic and postnatal devel-
opment remains unresolved.
Consistent with a role in tissue repair during development, a
recent manuscript reported that neonatal macrophages are
required for cardiac repair after neonatal myocardial infarction
(Aurora et al., 2014). After cardiac injury, neonatal macrophages
were required for angiogenesis and were associated with a less
vigorous inflammatory response when compared to macro-
phages in the injured adult heart. Unfortunately, this study did
not include a detailed characterization of monocyte and macro-
phage subsets or lineages. Prior studies in humans have also
described differences in inflammatory potential between fetal
and adult mononuclear phagocytes after LPS stimulation (Caron
et al., 2010; De Wit et al., 2003; Levy et al., 2004; Weatherstone
and Rich, 1989). Together, these findings suggest that em-
bryonic and neonatal macrophages play important roles in tissue
remodeling during development, and compared to adult-mono-
cyte-derived macrophages, they have a reduced capacity to
generate inflammatory responses.
Monocyte and Macrophage Dynamics and Function in
Tissues
Comprehensive transcriptional analysis of resident macro-
phages through the ImmGen Consortium suggests that
transcriptionally, resident macrophages isolated from various
organs are as different from each other as they are from circu-
lating blood monocytes during steady state (Gautier et al.,
2012b), suggesting that the tissue niche provides instructive
signals orchestrating macrophage differentiation. However,
because many resident macrophage populations consist of a
mixture of embryonic- and adult-HSC-derived macrophages
and because fate-mapping studies were not employed, we
must view the ImmGen data with the understanding that line-
age-specific functions among tissue macrophages were not
strictly assessed (Epelman et al., 2014; Hoeffel et al., 2012;
Schulz et al., 2012; Hashimoto et al., 2013). In this section, we
will highlight the relevant studies that allow us to discern how
different tissue macrophage populations change during times
of stress, whether functions possessed by macrophages during
embryonic development are ‘‘hard wired’’ and therefore retained
by their adult progeny, and how macrophages are conditioned
by the tissue in which they reside.
Brain Microglia and the Synapse—A Dynamic
Bidirectional Relationship
As mentioned previously, unlike other macrophage pools, brain
microglia are derived entirely from yolk sac macrophages; there-
fore, in the steady state, functions can be directly attributable to
this lineage. After birth, a massive expansion of microglia cell
numbers is driven exclusively through in situ proliferation via
M-CSF and interleukin-34 (IL-34) without monocyte input
Immunity
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Ajami et al., 2007). As in the embryo, microglia retain their ability
to alter neuronal circuitry during the postnatal period, where they
are critical for synaptic pruning through engulfment of neuronal
synapses, in addition to phagocytosis of apoptotic neurons
(Paolicelli et al., 2011). Specifically, Cx3cr1/mice have a tran-
sient reduction in microglia numbers during the early postnatal
period, incomplete synaptic pruning, and decreased functional
brain connectivity, resulting in neurodevelopmental abnormal-
ities related to social interaction and repetitive behaviors (Zhan
et al., 2014).
Microglia dynamically interact with neurons at both pre- and
postsynaptic sites through the extension of microglial pro-
cesses, where prolonged contact leads to elimination (Miyamoto
et al., 2013). During normal visual stimulation, microglia respond
to light-dark cycles by changing the frequency and duration of
contacts with multiple synapse-associated elements (Tremblay
et al., 2010). Interestingly, contact (and envelopment) by micro-
glia is correlated with subsequent changes in synaptic connec-
tions, suggesting that sensory experiences manipulate microglia
activity acutely, and microglia are involved in the modulation of
sensory processing by regulating synapses. Their role in the
steady-state adult brain can be ascertained through novel
genetic techniques that now allow for specific deletion of brain
microglia in the absence of the confounding effects of surgical
trauma with the use of the Cx3cr1CreER system. Specific micro-
glia deletion results in decreased synaptic formation and
learning (Parkhurst et al., 2013). Loss of microglia-specific
brain-derived neurotrophic factor produces a similar phenotype,
suggesting that a key steady-state function of microglia is pro-
moting synaptic plasticity of neurons in response to learning
cues secondary to the release of soluble mediators. During brain
ischemia, microglia significantly increase the duration of their in-
teractions with synapses, which correlates with the loss of
dysfunctional synaptic structures and suggests that microglia
serve an early protective role after brain injury (Wake et al., 2009).
Microglia and Recruited Monocytes during Brain Injury
Autoimmune experimental encephalitis (EAE) in the mouse is
similar to human multiple sclerosis and is believed to depend
on the activation of myelin-specific T cells that trigger resident
microglia and monocyte-derived macrophages, inflammatory
demyelination, and a relapsing and remitting motor paralysis.
Although this has been well investigated, we highlight two
studies in which the roles of resident microglia and recruited
monocytes were separated. Through the elegant use of mixed
parabiotic and bone-marrow-transplant studies, specific infiltra-
tion of monocyte-derived macrophages was both correlated to
and required for progression of neurological disease, indicating
a critical role for infiltrating monocytes in the pathogenesis of
EAE (Ajami et al., 2011). Utilizing the Cx3cr1CreER system, a
recent study has demonstrated that specific deletion of the
kinase TAK1 in microglia (and not infiltrating monocytes) pre-
vents both initial and relapsing paralysis, as well as inhibition of
cellular expansion and disease progression (Goldmann et al.,
2013). Together, these data suggest that both lineages are
required for EAE progression and that early microglia activation
via TAK1 is necessary for disease initiation, whereas the latter
monocyte infiltrate (which is dependent on microglia activation)
drives neurological damage through demyelization and progres-sion of paralysis. As in EAE, if monocytes are prevented from
infiltrating the brain after ischemic injury, the permeability of
the blood-brain barrier is reduced and infarct size is reduced,
suggesting a pathological role for monocyte-derived macro-
phages during ischemia (Dimitrijevic et al., 2007).
Whether or not monocytes enter the CNS is a difficult question
to address because it depends on the techniques utilized. For
example, with parabiosis, acute motor nerve damage leads to
microglia expansion that occurs without chimeric monocyte
input. However, if peripheral chimerism is achieved through irra-
diation and intravenous injection of large numbers of bone
marrow cells (standard bone-marrow-transplant studies),
chimeric blood monocytes are recruited to the sites of neuronal
injury (Ajami et al., 2007). Use of irradiation is a key confounder in
microglia dynamics, given that there is disruption of the blood-
brain barrier and entry of monocytes that would otherwise not
enter into the brain in the setting of adoptive transplant (Mildner
et al., 2011). During EAE, the microglia population expands
locally through proliferation, whereas recruited monocytes are
eliminated over time, suggesting that even during intense inflam-
mation, monocyte-derivedmacrophages do not have the capac-
ity to become self-sustaining microglia and have little long-term
access to the CNS (Ajami et al., 2011). Although many homeo-
static functions of yolk-sac-derived microglia are under intense
investigation, what has not been specifically addressed is the
relative ability of monocyte-derived macrophages to perform
highly specialized functions typically associated with microglia,
such as synaptic pruning. Monocyte-derived macrophages are
found in the CNS several months after EAE induction, and it
would be interesting to observewhether these cells, even though
their presence is temporary, are able to take over homeostatic
functions in brain areas in which they reside.
Neurodegenerative diseases are chronic disorders often asso-
ciated with aging and numerical expansion of microglia. During
the aging process, microglia acquire an irregular shape, occupy
smaller territories, and form inclusions containing apparent
synaptic elements, suggesting that dysfunction develops in
macrophage degradative pathways with age (Tremblay et al.,
2012; Wake et al., 2013). Similarly, in animal models of
Alzheimer’s disease, microglia numerically expand and progres-
sively accumulate beta amyloid plaques, which is believed to
impair phagocytic function and allow beta amyloid plaques to
accumulate in the brain, suggesting that phagocytosis of pla-
ques could be protective. SNPs in genes encoding CD33
(a phagocytosis inhibitor) or TREM2 (which mediates neuronal
uptake) are associated with Alzheimer’s disease, lending clinical
credence to the idea that impaired phagocytotic clearance of
plaque promotes disease progression (Griciuc et al., 2013; Guer-
reiro et al., 2013). Multiple studies have suggested that recruit-
ment of CCR2+ (Ly6chi) monocytes improves clearance of pla-
que depositions, improves cognitive function, and decreases
mortality in animal models of Alzheimer’s disease, suggesting
a clear protective role for infiltrating monocytes (Naert and Riv-
est, 2011; El Khoury et al., 2007). However, the use of irradiation
and bone-marrow-transplantation models to localize CCR2 defi-
ciency to the bone marrow compartment, which, as stated
above, might allow circulating monocytes access to the brain,
suggests that formal proof that monocytes enter the CNS in
Alzheimer’s models is currently lacking. In fact, there is strongImmunity 41, July 17, 2014 ª2014 Elsevier Inc. 27
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other neurodegenerative disorders (such as Huntington’s dis-
ease), but as of yet, the role of microglia in Huntington’s disease
is not clear (Ajami et al., 2007). Understanding the role of mono-
cytes and microglia in neurocognitive dysfunction is challenging
because subtle dysfunctionsmight not be readily detectable. For
example, Cx3cr1/mice have been widely utilized over the last
decade in multiple fields, and as mentioned above, we have only
recently identified neurocognitive deficits related to microglia in
this strain (Zhan et al., 2014). Together, these data demonstrate
that resident microglia have important homeostatic functions in
regulating synaptic development, and the diseased state (e.g.,
Alzheimer’s disease) might be insufficient to prevent chronic
neurodegeneration. Taking advantage of macrophage plasticity
in the setting of dysfunctional brain microglia by promoting
monocyte entry could lead to novel therapeutic approaches for
neurocognitive disorders.
Cardiac Macrophages—Ontologically and Functionally
Distinct Subsets
Unlike the brain, which exclusively contains yolk-sac-derived
microglia, the heart contains several discrete macrophage pop-
ulations with mixed ontological origins (Epelman et al., 2014).
CCR2 macrophages are largely derived from embryonic pro-
genitors, including contributions from yolk sac macrophages,
and are primarily autonomous from blood monocytes. In
contrast, resident cardiac CCR2+ macrophages are derived
entirely from definitive HSCs and are replaced slowly by blood
monocytes. In the setting of acute hypertensive stress, both
resident embryonically derived macrophage populations and
recruited populations expand by proliferation in a manner
analogous to that of peritoneal macrophages during sterile
inflammation (Davies et al., 2013b). Functionally, when all car-
diac macrophages are depleted after ischemic injury, a net
beneficial role in scar formation is revealed, given that macro-
phage-depleted mice demonstrate poor infarct healing and
myocardial rupture (van Amerongen et al., 2007; Nahrendorf
et al., 2007). Subset-specific transcriptional profiling indicates
that CCR2+ macrophages differentially express multiple compo-
nents of the NLRP3 inflammasome and are required for IL-1b
production, suggesting that adult-derived macrophage lineages
within the myocardium might be primed to generate inflamma-
tory responses (Epelman et al., 2014). These data could help
explain why targeting CCR2+ macrophages is beneficial after
ischemic injury (Frangogiannis et al., 2007). Whether reparative
and proangiogenic responses are mediated by adult and/or
embryonically established macrophage populations remains un-
known.
Depletion, Plasticity, and Function of Tissue
Macrophages
After depletion of cardiac macrophages, circulating Ly6chi
monocytes take up permanent residence within cardiac tissue
and give rise to the dominant population of resident tissue mac-
rophages. After repopulation is complete, autonomy of tissue
macrophages is restored, albeit with a large complement of
adult-monocyte-derived macrophages as the new resident
macrophage population (Epelman et al., 2014). If Ly6chi mono-
cytes are absent from circulation (such as in Ccr2/mice), resi-
dent macrophages are fully capable of repopulating the tissue
niche (see Figure 3). Careful examination of the repopulation of28 Immunity 41, July 17, 2014 ª2014 Elsevier Inc.tissue macrophages after depletion has revealed that multiple
mechanisms are at play. As a result, a universally applied repo-
pulation strategy does not exist, because both organ- and deple-
tion-specific factors apply. For example, similar to depletion of
cardiac macrophages, clodronate-liposome-mediated deple-
tion results in profound and permanent loss of embryonically
established resident tissue macrophages, including liver Kupffer
cells and splenic red-pulp macrophages. Both Kupffer cells and
splenic red-pulp macrophages are subsequently replacement
by adult-derived (FLT3-dependent) monocytes, indicating that
circulating monocytes have a competitive advantage over the
remaining resident tissue macrophages (Epelman et al., 2014).
These data indicate that forced ‘‘ontological reprogramming’’
of tissue macrophages can be easily achieved with clodronate-
liposome-mediated depletion strategies in these organs. The
functional significance of ontological reprogramming is un-
known, and defining whether distinct macrophage lineages
harbor unique or overlapping functions will require tissue-spe-
cific investigations.
Alveolar macrophages reside on the epithelial surface of the
lung, and in contrast to other resident macrophage populations,
they are in direct contact with the environment, which includes
commensal bacteria, inhaled particulates, and host-epithelial-
derived factors, such as surfactants. Embryonically derived fetal
monocytes appear to colonize the lung shortly after birth and
differentiate into alveolar macrophages in a GM-CSF-dependent
process (Guilliams et al., 2013). GM-CSF signaling drives
expression of PPAR-g, a characteristic feature of alveolar mac-
rophages (Malur et al., 2011), which contributes to the unique
gene-expression profile of lung macrophages (Gautier et al.,
2012a). Alveolar macrophages normally live independently of
blood monocyte input; however, an interesting competition
takes place if alveolar macrophages are depleted. CD163-
DTR-mediated depletion results in repopulation by in situ prolif-
eration independently of bloodmonocyte input (Hashimoto et al.,
2013) (see Figure 3). However, if alveolar macrophages are
depleted by genotoxic injury via lethal irradiation, recruited
monocytes now gain the competitive advantage and repopulate
the alveolar macrophage niche. Intriguingly, despite genotoxic
injury, irradiated resident alveolar macrophages can re-expand
if recruited monocytes cannot receive GM-CSF signals. Use of
sublethal irradiation seems to level the playing field such that
both resident macrophages and blood monocytes contribute
to repopulation. Functionally, similar observations have also
been seen in the heart (Epelman et al., 2014). These data indicate
that most resident tissue macrophages maintain themselves
indefinitely without monocyte input, but if an acute and profound
depletion occurs, circulating monocytes can readily repopulate
the macrophage niche.
Pulmonary surfactant is produced by alveolar epithelial cells,
and together with other pathways, it acts to suppress alveolar
macrophage activation during resting conditions (Hussell and
Bell, 2014). An essential role of alveolar macrophages is the
ability to phagocytose excessive surfactant proteins and prevent
alveolar proteinosis (Dranoff et al., 1994; Guilliams et al., 2013).
After alveolar macrophage depletion, local production of GM-
CSF is essential for both alveolar macrophages and recruited
monocytes to reverse alveolar proteinosis (Hashimoto et al.,
2013), again highlighting the ability of the tissue niche to govern
Figure 3. Schematic Representation of Repopulation Strategies Used by Tissues to Replenish Macrophage Numbers via Different
Depletions Methods
(A) Cardiac macrophages. In the steady state, the majority of cardiac macrophages are embryonically derived (red, Flt3-Cre), and a smaller contribution is
derived from HSCs (green, Flt3-Cre+). After depletion, Ly6chi monocytes enter into tissue, proliferate, and compete with proliferating resident cardiac macro-
phages to reestablish the steady-state macrophage pool. After repopulation is complete, autonomy between tissue macrophages and monocytes is restored.
The pool of resident cardiac macrophages has undergone ‘‘ontological reprogramming’’ and is now primarily composed of adult-derived macrophages. In the
absence of circulating blood monocytes (such as in Ccr2/ mice), resident cardiac macrophages are fully capable of reestablishing steady-state levels solely
through in situ proliferation.
(B) Alveolar macrophages. In the steady state, themajority of alveolar macrophages are derived from embryonic progenitors, and a smaller contribution is derived
from HSCs. Alveolar macrophages are instructed by GM-CSF to differentiate into functional alveolar macrophages that prevent alveolar proteinosis. After
depletion (CD163-DTR), numbers of resident macrophages are reduced, and repopulation occurs solely through in situ proliferation of resident lung macro-
phages. If resident macrophages receive significant genotoxic injury (lethal irradiation) as a depletion strategy, recruitedmonocytes gain a competitive advantage
and replace resident, embryonically derived lung macrophages. If recruited monocytes cannot receive GM-CSF signals, then alveolar macrophages, despite
genotoxic injury, are capable of repopulating the lung macrophage niche.
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lineage.
Splenic red-pulp macrophages are required to take up senes-
cent red blood cells and specifically utilize the transcription fac-
tor SPI-C to drive the genes necessary for iron uptake (Kohyama
et al., 2009). Unlike other embryonically derived macrophages,
splenic red-pulp macrophages receive instructive signals from
the spleen to express SPI-C, highlighting clear tissue-specific
steady-state functions. In the setting of hemolysis, excessive
heme induces the loss of resident red-pulp macrophages. Circu-
lating monocytes enter the spleen and upregulate SpiC, leading
to macrophage differentiation, reestablishment of the splenic
red-pulp macrophage compartment, and restoration of iron
homeostasis. These data provide further evidence that local
signaling within tissues might be sufficient to promote the acqui-
sition of specialized macrophage functions irrespective of the
ontological lineage (Haldar et al., 2014).
Splenic marginal-zone macrophage development is depen-
dent on the nuclear receptor LXR and functions to limit blood-
borne infections (A-Gonzalez et al., 2013). Although the precise
origin of marginal-zone macrophages is not known, these cells
proliferate in the first weeks of life. LXR-deficient mice have
normal monocyte numbers, and adoptive transfer of wild-type
monocytes into LXR-deficient mice leads to functional reestab-
lishment of the splenic marginal-zone macrophage niche, indi-
cating that monocytes are instructed within the spleen in a
LXR-dependent manner to acquire marginal-zone macrophage
fate. Together, these data highlight the ability of the spleen to
drive monocyte-to-macrophage differentiation and compart-
mentalize monocyte fate to specific splenic macrophage sub-
sets (red pulp verses marginal zone).
However, it remains unclear whether the tissue microenviron-
ment is sufficient to induce tissue-specific macrophage mRNA
transcripts in organs beyond the spleen. GATA6 is a transcription
factor that selectively regulates peritoneal macrophage tran-
scripts (Gautier et al., 2014; Gautier et al., 2012b; Okabe and
Medzhitov, 2014; Rosas et al., 2014). In the absence of
GATA6, the major resident macrophage population in the perito-
neum is greatly contracted, but a second, smaller population that
normally lacks GATA6 expression remains at normal frequency
(Gautier et al., 2014; Okabe and Medzhitov, 2014; Rosas et al.,
2014). Enhanced apoptosis in the resting state (Gautier et al.,
2014) and a failure to proliferate in states of inflammation (Rosas
et al., 2014) explain the loss of macrophages. GATA6 can be
induced by vitamin A signaling, but addition of vitamin A to
cultured macrophages will induce GATA6 only when sources
of fetal macrophages, such as fetal-liver macrophages, are
used (Okabe and Medzhitov, 2014). A working model is that
mature macrophages have undergone epigenetic changes that
prevent such induction, such that GATA6 has not yet been
demonstrated to be induced in monocytes or other macro-
phages from adult mice. In line with this model, GATA6 is not
induced in monocyte-derived macrophages recruited to the
peritoneum during thioglycollate-elicited inflammation. These
elicited macrophages upregulate canonical, universal macro-
phage differentiation transcripts, but they induce only some peri-
toneal-cavity-selective transcripts (Gautier et al., 2012b). It will
be important to determine in the future whether the ablation of
resident peritoneal macrophages provides a niche in which re-30 Immunity 41, July 17, 2014 ª2014 Elsevier Inc.cruited monocytes can replace them with induction of the full
panoply of local resident macrophage transcripts, including
GATA6 and its targets.
Macrophages and Tissue Regeneration
One of the most interesting aspects of macrophage function is
their involvement in tissue repair and regeneration. Model organ-
isms, including salamanders, zebrafish, and neonatal mice, all
require macrophages for tissue regeneration; however, no
studies have addressed the contribution of distinct macrophage
subtypes and/or lineages in this process (Godwin et al., 2013;
Aurora et al., 2014; Huang et al., 2013). The liver is the best char-
acterized adult organ capable of regeneration in mammals after
injury or resection. Macrophage expansion occurs in the setting
of injury, and a significant component occurs through monocyte
recruitment, although specifics regarding the contribution of
resident versus recruited cells are lacking. After injury, liver
macrophages engulf hepatocyte debris and activate a program
leading to the secretion of WNT ligands, which direct hepatocyte
differentiation from progenitors (You et al., 2013; Boulter et al.,
2012). Although macrophage depletion impairs hepatocyte dif-
ferentiation, bile duct regeneration is not affected, highlighting
the potential specificity of macrophage-mediated regeneration.
In the absence of circulating monocytes (such as in CCR2- or
MCP-1-deficient mice), fibrosis after acute liver injury or diet-
induced nonalcoholic liver disease is reduced, suggesting that
monocyte-derived macrophages rather than Kupffer cells pro-
mote liver fibrosis (Kassel et al., 2010; Karlmark et al., 2009).
The ability to induce fibrosis at the site of injury appears to be
a common function of recently recruited monocytes, not only
in the liver but also in the heart and kidney, suggesting a
conserved transcriptional program (Kaikita et al., 2004; Kitagawa
et al., 2004). Studies that focus on the role of monocyte-derived
macrophages invariably target the CCR2 pathway, which also
limits monocyte egress from the bone marrow during steady
state. CCR2 deficiency serves as our best model of peripheral
monocyte ablation, but several important caveats must be taken
into account. CCR2 is also required for HSCs to traffic to sites of
injury (such as the liver), and CCR2 signaling in nonimmune cells
might also promote injury (Si et al., 2010; Zhou et al., 2006).
Given recent advances in our understanding of macrophage
ontogeny, novel genetic tools for and approaches to separating
out functions of infiltrating monocytes from resident em-
bryonically derived and adult-derived macrophages are being
developed. Future studies will focus on deciphering the function
of individual pathways (such as TAK1 in microglia) within distinct
macrophage lineages. Commonmacrophage functions, such as
phagocytosis, could be easily complemented by nonresident
monocyte-derived macrophages. Whether specialized macro-
phage functions are specific to resident macrophage lineages
or can be fully acquired by recruited, monocyte-derived macro-
phages remains an important question and will require careful
examination.
Monocyte and Macrophage Proliferation in Tissues
Macrophage expansion in tissues during disease is common and
critically modulates injury versus healing. However, the contribu-
tion of monocyte recruitment and local proliferation is only now
coming to light. Until the demonstration that proliferation of mac-
rophages could solely account for macrophage expansion at
sites of nematode infection, macrophage proliferation was not
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within organs. IL-4 signals serve in this context as a major
driver of proliferation, raising the initial idea that macrophage
proliferation is a particularly specialized feature of T helper 2
(Th2)-cell-oriented immunity (Jenkins et al., 2011; Jenkins
et al., 2013). Cardiac injury and sterile peritonitis induce
monocyte recruitment and subsequent proliferation in tissues
of resident macrophages, recruited monocytes, and mono-
cyte-derived macrophages (Davies et al., 2013b; Epelman
et al., 2014). Recent studies of adipose tissue and atheroscle-
rosis suggest that macrophage proliferation contributes to
inflammation in contexts beyond Th2 cell immunity. Understand-
ing whether monocyte recruitment or proliferation of resident
and recruited macrophages drives expansion is critical if thera-
pies targeting macrophages are to move forward. For example,
if local macrophage expansion is sufficient to mediate pathol-
ogy, blockade of monocyte recruitment would be expected to
only modestly affect disease progression.
Recruitment and proliferation appear to be intertwined.
Macrophage proliferation in adipose tissue has been reported
to be dependent on MCP-1, as is monocyte emigration from
bone marrow and entry into circulation and peripheral tissue
(Serbina and Pamer, 2006; Amano et al., 2014). As opposed to
the idea that MCP-1-CCR2 signaling in adipose tissue macro-
phages drives proliferation directly, it seemsmore likely that pro-
liferation of macrophages is coupled to signals downstream of
CCR2-mediated monocyte recruitment. The concept of coupled
proliferation and recruitment also extends to atherosclerosis.
There is significant evidence that early in disease progression,
recruited monocytes enter into plaque, take up cholesterol,
and become dysfunctional foam cells. Blockade of monocyte
recruitment prevents disease progression (Randolph, 2014).
However, recent data also generate a compelling case for prolif-
eration as a major determinant for macrophage burden within
plaques (Robbins et al., 2013).
What is clear is that recruited monocytes, monocyte-derived
macrophages, and resident macrophages utilize proliferation
as a strategy to control cell numbers within tissue. Given that
monocyte numbers can be augmented simply through additional
recruitment, the readermight ask, why domonocytes andmono-
cyte-derived macrophages proliferate in tissues? One possibility
is that local expansion and contraction could be a more efficient
and tightly regulated process. If local expansion (of resident
macrophages) is insufficient, increased production and release
of monocytes from bonemarrow and splenic stores could be uti-
lized (Swirski et al., 2009). However, as a generalized mecha-
nism, increased peripheral monocyte production and release in
the hopes that those short-lived cells rapidly and specifically
enter an inflamed tissue appears less efficient. The very recent
identification of proliferating Ly6c+ monocyte progenitors in the
spleen and bone marrow might reveal another nuanced mecha-
nism in which injured tissue recruits monocyte progenitors that
locally proliferate and thus give the tissue an opportunity to con-
trol monocyte numbers in situ rather than through recruitment.
Monocyte recruitment and local proliferation are unlikely to be in-
dependent mechanisms. In fact, the currently available evidence
supports a model in which recruitment of monocytes is linked to
proliferation of previously recruited monocyte-derived macro-
phages (Randolph, 2013).Human Correlates to Ontologically Distinct Tissue
Macrophage Subsets
Few studies have examined whether human tissue macro-
phages are similarly composed of resident embryonically
derived and monocyte-derived macrophage subsets. Instead,
designation of macrophage populations in humans has largely
been focused on defining cell types on the basis of the M1 (inter-
feron-g-mediated) versus M2 (IL-4-mediated) macrophage
phenotype. The M1 versus M2 designation is a widely utilized
paradigm in mice and appears to be conserved to some degree
in humans (Martinez et al., 2013). However, a recent study has
demonstrated that treatment of human blood monocytes with
a variety of stimuli results in acquisition of a spectrum of macro-
phage phenotypes that span between classic M1 and M2 defini-
tions, casting doubt on the concept that M1 versus M2 behavior
can be used for defining macrophage subsets (Xue et al., 2014;
Murray et al., 2014, in this issue of Immunity).
Studies focusing on human skin after HSC transplantation
have revealed indirect evidence that tissue macrophages are
long lived and might exist independently of circulating progeni-
tors. Careful examination of skin HLA-DR+ myeloid cells from
patients receiving sex-mismatched bone marrow transplants
demonstrated that DC populations reached nearly 100% chime-
rism within 40 days posttransplant, indicating a clear depen-
dency on circulating cells (Haniffa et al., 2009). However,
25% of skin macrophages were not replaced, even after 1
year posttransplant, suggesting that some human skin resident
macrophages might persist independently of circulating mono-
cyte input, which is similar to what has been observed in mice
(Jakubzick et al., 2013; Tamoutounour et al., 2013).
Because genetic lineage tracing is not feasible in humans, the
optimal strategy for identifying and defining distinct macro-
phage lineages in human tissue is not immediately obvious.
Identification of conserved gene-expression signatures repre-
sents one potential solution to this problem. Systematic anal-
ysis of the ImmGen data set from C57Bl/6 mice has yielded
the discovery of a core macrophage gene-expression signa-
ture, allowing the distinction of monocytes, macrophages,
and DCs (Gautier et al., 2012b). Major surface proteins found
in the core signature include Mer tyrosine kinase and FcgRI,
molecules that themselves highlight the specialized function
that macrophages have in engulfing apoptotic cells and re-
sponding to immunoglobulins made during adaptive immunity
to coordinate tissue responses, respectively. Importantly, Mer
tyrosine kinase and FcgRI were recently shown to also be
conserved in human monocyte-derived macrophages (Xue
et al., 2014). With this methodology, it is conceivable that by
defining the core signatures of embryonically derived and
monocyte-derived macrophage subsets in mice, it might be
possible to identify corresponding macrophage populations in
humans.
Summary
There are clear examples in which tissue-specific factors drive
highly specialized macrophage functions irrespective of their
ontological origin, suggesting tremendous plasticity and redun-
dancy in the mononuclear phagocyte system. Whether embry-
onic and adult macrophages possess specialized roles has yet
to be formally tested. However, our conceptual understandingImmunity 41, July 17, 2014 ª2014 Elsevier Inc. 31
Table 2. Future Directions
Do tissue macrophages that live in mixed ontological lineages differ
transcriptionally?
Does targeting tissue macrophages on the basis of ontological
lineage reveal differential functions?
What is the extent of tissue macrophage plasticity?
Why do tissue macrophages proliferate during inflammation?
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Reviewand genetic tools are now sufficiently developed to precisely
follow both embryonic and adult macrophage subsets in health
and disease, which should allow important and unanswered
questions in the field to be addressed (see Table 2). In order to
develop novel therapies, a critical future goal is to harness this
newfound understanding that different macrophage lineages
exist within tissues and clarify whether these distinct lineages
differentially contribute to tissue damage and repair.
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